inclusion criteria: * age ≥ 18 * diagnosis of covid19 by validated sars-cov-2 antigen, rt-pcr, or other molecular diagnostic assay, using an appropriate sample such as np, nasal, oropharyngeal \[op\], or saliva) and no alternative explanation for current clinical condition. * respiratory failure requiring oxygen therapy * has symptoms consistent with covid-19, and is in non-fibroproliferative stage of disease, as determined by investigator.

inclusion criteria: * age ≥ 18 * diagnosis of covid19 by validated sars-cov-2 antigen, rt-pcr, or other molecular diagnostic assay, using an appropriate sample such as np, nasal, oropharyngeal \[op\], or saliva) and no alternative explanation for current clinical condition. * respiratory failure requiring oxygen therapy * has symptoms consistent with covid-19, and is in non-fibroproliferative stage of disease, as determined by investigator.

inclusion criteria: - age ≥ 18 - diagnosis of covid19 by validated sars-cov-2 antigen, rt-pcr, or other molecular diagnostic assay, using an appropriate sample such as np, nasal, oropharyngeal [op], or saliva) and no alternative explanation for current clinical condition. - respiratory failure requiring oxygen therapy - has symptoms consistent with covid-19, and is in non-fibroproliferative stage of disease, as determined by investigator.

inclusion criteria: - age ≥ 18 - diagnosis of covid19 by validated sars-cov-2 antigen, rt-pcr, or other molecular diagnostic assay, using an appropriate sample such as np, nasal, oropharyngeal [op], or saliva) and no alternative explanation for current clinical condition. - respiratory failure requiring oxygen therapy - has symptoms consistent with covid-19, and is in non-fibroproliferative stage of disease, as determined by investigator.